期刊文献+

36例亚临床甲减伴高脂血症患者治疗前后血脂变化的分析 被引量:5

Analysis of Lipid Levels Before and After the Treatment in 36 Patients with Subclinical Hypothyroidism and Hyperlipidemia.
下载PDF
导出
摘要 目的探讨亚临床甲状腺功能减退症(简称亚临床甲减)合并高脂血症患者,使用左旋甲状腺素治疗前后血脂水平的变化。方法检测36例亚临床甲减合并高脂血症患者促甲状腺素(TSH)、血清总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇水平(LDL-C),使用左旋甲状腺素钠(L-T4)替代治疗,剂量平均50-75μg/d,以TSH调整在正常范围为合适剂量,12周后复查TSH及血脂水平,观察12周后的血脂改善情况。结果亚临床甲减伴高脂血症患者经治疗后血脂改善明显,与治疗前相比存在显著性差异(P<0.05)。结论亚临床甲减伴高血脂症患者经左旋甲状腺素治疗后,血脂情况明显改善。 Objective The aim of the study was to compare the lipid levels before and after levothyroxine treatment in patients with subclinical hypothyroidism and hyperlipidemia. Methods Test thyroid-stimulating hormone (TSH), total cholesterol, triglycerides and low-density lipoprotein cholesterol levels of 36 patients with subclinical hypothyroidism and hyperlipidemia,use levothyroxine sodium (L-T4)as replacement therapy at the average dose 50-75 μg/d, adjusting the appropriate dose with TSH in the normal range, observe the TSH and lipid levels after 12 weeks. Result The lipids decreased manifest after treatment in patients with subclinical hypothyroidism and hyperlipidemia. And the difference is significant(P〈0.05). Conclusion After levothyroxine therapy, serum lipids improve remarkably in patients with subclinical hypothyroidism and hyperlipidemia.
作者 柯翌子
出处 《中国医药指南》 2013年第3期1-2,共2页 Guide of China Medicine
关键词 亚临床甲状腺功能减退症 高脂血症 左旋甲状腺素 Tubclinical hypothyroidism Hyperlipidemia L-T4
  • 相关文献

参考文献5

二级参考文献20

  • 1Chu JW,Crapo LM.The treatment of Subclinical hy pothy roidism is seldom necessary[J].J Clin Endocrinol Metab,2001,86:4591-4599.
  • 2Luboshitzky R,Aviv A,Herer P,et al.Risk factors for cardiovascular disease in women with subclinical hypothyroidism[J].Thyroid,2002,12(5):421-425.
  • 3Muller B,Tsakiris DA,Roth CB,et al.Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease[J].Eur J Clin Invest,2001,31(2):131-137.
  • 4Kahaly GJ.Cardiovascular and atherogenic aspects of subclinical hypothyroidism[J].Thyroid,2000,10(8):665-679.
  • 5Altinova AE,Toruner FB,Akturk M,et al.Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism[J].Clin Endocrinol(Oxf),2006,65(4):530-535.
  • 6Sasaki S,Kawai K,Honjo Y,et al.Thyroid hormones and lipid metabolism[J].Nippon Rinsho,2006,64(12):2323-2329.
  • 7Berti JA,Amaral ME,Boschero AC.Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice[J].Metabolism,2001,50(5):530-536.
  • 8Huesca-Gomez C,Franco M,Luc G,et al.Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat[J].Metabolism,2002,51 (4):443-450.
  • 9Isaacs A,Aulchenko YS,Hofman A,et al.Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum HDL-c levels[J].J Clin Endocrinol Metab,2007,92(7):2680-2687.
  • 10Duntas LH.Thyroid disease and lipids[J].Thyroid,2002,12(4):287-293.

共引文献56

同被引文献42

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部